Brief: Appili Therapeutics Names Infectious Disease Specialist Yoav Golan, MD, As Its Chief Medical Officer
21/04/2020 12:20
April 21 (Reuters) - Appili Therapeutics Inc APLI.V :
* APPILI THERAPEUTICS NAMES INFECTIOUS DISEASE SPECIALIST
YOAV
GOLAN, MD, AS ITS CHIEF MEDICAL OFFICER
Source text for Eikon: ID:nBw7swTh7a
Further company coverage: APLI.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Appili Therapeutics
See all newsBrief: Appili Therapeutics Announces Closing Of Second Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Closes First Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Formal Termination Of Arrangement Agreement With Aditxt
Brief: Appili Therapeutics Announces New Patents Granted For Commercial Stage Asset Likmez